A detailed history of Efg Asset Management (Americas) Corp. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Efg Asset Management (Americas) Corp. holds 14,953 shares of ALNY stock, worth $3.49 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
14,953
Previous 16,992 12.0%
Holding current value
$3.49 Million
Previous $4.13 Million 0.39%
% of portfolio
0.81%
Previous 0.81%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$233.81 - $287.01 $476,738 - $585,213
-2,039 Reduced 12.0%
14,953 $4.11 Million
Q2 2024

Aug 06, 2024

BUY
$143.31 - $247.0 $875,050 - $1.51 Million
6,106 Added 56.09%
16,992 $4.13 Million
Q1 2024

Apr 22, 2024

SELL
$146.51 - $198.2 $786,026 - $1.06 Million
-5,365 Reduced 33.01%
10,886 $1.63 Million
Q4 2023

Feb 01, 2024

BUY
$151.41 - $196.57 $120,219 - $156,076
794 Added 5.14%
16,251 $3.11 Million
Q3 2023

Nov 09, 2023

SELL
$170.77 - $211.65 $47,474 - $58,838
-278 Reduced 1.77%
15,457 $2.74 Million
Q2 2023

Aug 29, 2023

BUY
$185.01 - $212.05 $102,865 - $117,899
556 Added 3.66%
15,735 $2.99 Million
Q1 2023

May 04, 2023

SELL
$182.66 - $235.53 $43,473 - $56,056
-238 Reduced 1.54%
15,179 $3.04 Million
Q4 2022

Feb 09, 2023

BUY
$185.53 - $241.31 $51,020 - $66,360
275 Added 1.82%
15,417 $3.66 Million
Q3 2022

Nov 07, 2022

BUY
$138.54 - $232.0 $262,256 - $439,176
1,893 Added 14.29%
15,142 $3.03 Million
Q2 2022

Jul 13, 2022

SELL
$120.42 - $169.29 $420,145 - $590,652
-3,489 Reduced 20.84%
13,249 $1.93 Million
Q1 2022

May 05, 2022

BUY
$127.18 - $173.91 $2.13 Million - $2.91 Million
16,738 New
16,738 $2.73 Million
Q3 2021

Oct 22, 2021

SELL
$169.75 - $207.73 $4.45 Million - $5.44 Million
-26,187 Closed
0 $0
Q2 2021

Jul 23, 2021

BUY
$128.63 - $176.89 $224,716 - $309,026
1,747 Added 7.15%
26,187 $4.44 Million
Q1 2021

Apr 09, 2021

BUY
$126.83 - $175.69 $129,366 - $179,203
1,020 Added 4.36%
24,440 $3.45 Million
Q4 2020

Feb 05, 2021

BUY
$122.97 - $147.0 $287,872 - $344,127
2,341 Added 11.11%
23,420 $3.04 Million
Q3 2020

Nov 06, 2020

BUY
$121.19 - $165.49 $2.55 Million - $3.49 Million
21,079 New
21,079 $3.07 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $28.7B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Efg Asset Management (Americas) Corp. Portfolio

Follow Efg Asset Management (Americas) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.